Keyphrases
T-cell Lymphoma
100%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
100%
Non-Hodgkin Lymphoma
85%
Human Immunodeficiency Virus Type 1 (HIV-1)
57%
Lymphoma Patients
57%
CD4+ T
42%
Prevalence Rate
42%
Blood Donors
42%
Cell Lymphoma
42%
HIV-2
28%
HTLV-II
28%
United States
14%
Clinical Trials
14%
Family Members
14%
Poor Prognosis
14%
African American
14%
Lymphoma
14%
B-cell Lymphoma
14%
PCR Assay
14%
Patient Demographics
14%
HIV-positive
14%
Retroviral Infection
14%
HTLV-I Infection
14%
African American Health
14%
Human Retrovirus
14%
Blood Products
14%
Body Donation
14%
Thrombocytosis
14%
Plasma Products
14%
Hemophiliacs
14%
Gay People
14%
Groups at Risk
14%
Sexual Contact
14%
Healthcare Clinic
14%
Serologic Assays
14%
Pooled Plasma
14%
Intravenous Drug Users
14%
American Health Care
14%
HIV-2 Infection
14%
Needlestick
14%
Prostitutes
14%
Medicine and Dentistry
Prevalence
100%
Human Immunodeficiency Virus
100%
T-Cell Lymphoma
100%
Human T-Lymphotropic Virus 1
100%
Human T Cell Leukemia Virus
87%
Non-Hodgkin Lymphoma
75%
Blood Donor
50%
T-Helper Cell
37%
Human T-Lymphotropic Virus 2
25%
Health Care
12%
Infection
12%
Clinical Trial
12%
B-Cell Lymphoma
12%
Patient Population
12%
High Risk Population
12%
Retrovirus Infection
12%
Volunteer
12%
Blood Product
12%
Thrombocytosis
12%
Human Immunodeficiency Virus 2 Infection
12%
African American Health
12%
Human T Cell Leukemia Virus Infection
12%
Needlestick Injury
12%
Diseases
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
HIV
100%
T Cell Lymphoma
100%
Human T-Lymphotropic Virus 1
100%
Human T Cell Leukemia Virus
87%
Nonhodgkin Lymphoma
75%
Human T-Lymphotropic Virus 2
25%
Infection
12%
Clinical Trial
12%
B Cell Lymphoma
12%
Retrovirus Infection
12%
Thrombocytosis
12%
Human T Cell Leukemia Virus Infection
12%
Human Immunodeficiency Virus 2 Infection
12%
Needlestick Injury
12%
Diseases
12%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Prevalence
100%
Human T Cell Leukemia Virus
100%
Human T-Lymphotropic Virus 1
100%
Human Immunodeficiency Virus
62%
Human Immunodeficiency Virus 1
50%
CD4
37%
Human T-Lymphotropic Virus 2
25%
Clinical Trial
12%
B Cell
12%
High Risk Population
12%
Thrombocytosis
12%
Blood Product
12%
Retrovirus
12%
Blood Plasma
12%
Immunology and Microbiology
Prevalence
100%
T Cell
100%
Human T-Lymphotropic Virus 1
100%
Human T Cell Leukemia Virus
100%
Human Immunodeficiency Virus
62%
Human Immunodeficiency Virus 1
50%
T-Helper Cell
37%
Human T-Lymphotropic Virus 2
25%
Blood Plasma
12%
B Cell
12%
High Risk Population
12%
Blood Product
12%
Retrovirus Infection
12%
Nursing and Health Professions
Prevalence
100%
Human Immunodeficiency Virus
100%
T Cell Lymphoma
100%
Nonhodgkin Lymphoma
75%
Blood Donor
50%
Hospital
12%
Infection
12%
Volunteer
12%
Patient Population
12%
High Risk Population
12%
Drug Use
12%
B Cell Lymphoma
12%
Retrovirus Infection
12%
Needlestick Injury
12%
Thrombocytosis
12%
Human T Cell Leukemia Virus Infection
12%
Human Immunodeficiency Virus 2 Infection
12%
Diseases
12%
Health Care
12%